Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 14Breast Neoplasms 14Neoplasms 10Head and Neck Neoplasms 8Carcinoma, Squamous Cell 8Lung Neoplasms 7Leukemia, Myeloid, Acute 7Glioblastoma 7Colorectal Neoplasms 7Ovarian Neoplasms 6Neoplasm Metastasis 6Recurrence 5Pancreatic Neoplasms 5Melanoma 5Leukemia 5Prostatic Neoplasms 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Lymphoma, Non-Hodgkin 4Fallopian Tube Neoplasms 4Anemia, Refractory, with Excess of Blasts 4Squamous Cell Carcinoma of Head and Neck 3Small Cell Lung Carcinoma 3Rectal Neoplasms 3Lymphoma, Follicular 3Colonic Neoplasms 3Brain Neoplasms 3Treatment 2Sarcoma 2Pleural Effusion, Malignant 2Pharyngeal Neoplasms 2

Interventions

Gemcitabine 13Cisplatin 8Capecitabine 8Fluorouracil 5pembrolizumab 4Oxaliplatin 4Sorafenib 3Leucovorin 3Erlotinib Hydrochloride 3trametinib 2regorafenib 2durvalumab 2N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl-6-(5-((methylsulfonyl)ethyl)aminomethyl)-2-furyl)-4-quinazolinamine 2Magnetic Resonance Spectroscopy 2Lapatinib 2trifluridine tipiracil drug combination 1tremelimumab 1spartalizumab 1seribantumab 1olutasidenib 1olaparib 1devimistat 1derazantinib 1dehydroftorafur 1cediranib 1cabozantinib 1Trifluridine 1Trastuzumab 1Therapeutics 1Sutures 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Bile Duct Neoplasms × Drug Therapy × Clear all
NCT02082522 2019-08-28

Efficacy and Safety Study of PDT Using Photofrin in Unresectable Advanced Perihilar Cholangiocarcinoma (OPUS)

Concordia Laboratories Inc.

Phase 3 Terminated
28 enrolled 24 charts
Gastrointestinal

Bile Duct Neoplasms, Cholangiocarcinoma, Klatskin Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡